Johnson & Johnson on Monday said it plans to reduce by at least 80% its stake in Kenvue, the consumer health business it spun out as an independent company earlier this year, via a stock exchange offer.
J&J owns 89.6% of Kenvue's common stock, which amounts to more than 1.72 billion shares.
The exchange offer, also known as a split-off, will allow J&J shareholders to swap all or a portion of their shares for Kenvue's common stock at a 7% discount.
J&J first announced its intent to launch an exchange offer in its second-quarter earnings report on Thursday, but the company provided few details on the plan.
When asked about J&J's planned exchange offer on Thursday, Kenvue CEO Thibaut Mongon told CNBC's "Squawk on the Street" that the company is "pleased with the way that the IPO has been received by shareholders."
Persons:
Johnson, J, Joaquin Duato, Duato, Kenvue, J's, Thibaut Mongon, CNBC's
Organizations:
J
Locations:
Kenvue